$MLNT News Article - Melinta Therapeutics Announces U.S. FDA Acceptance of Supplemental New Drug Application for BAXDELA (delafloxacin) for the Treatment of Community-Acquired Bacterial Pneumonia
https://marketwirenews.com/news-releases/meli...80734.html